Literature DB >> 7089866

Blood-brain barrier derangement in uremic encephalopathy.

B Jeppsson, H R Freund, Z Gimmon, J H James, M F von Meyenfeldt, J E Fischer.   

Abstract

A disturbance of cerebral neurotransmitters and an accumulation of octopamine, a putative false neurotransmitter, have been found in patients with uremic encephalopathy who manifest disorientation, somnolence, asterixis, and coma--symptoms also seen in portal systemic encephalopathy (PSE). Altered plasma concentrations of the neutral amino acids (NAAs) and increased blood-brain NAA transport may play a role in PSE, and in the present study plasma amino acid concentrations and blood-brain barrier NAA transport were investigated in rats with acute and chronic uremia. Acute uremia was produced by unilateral nephrectomy and occlusion of the renal artery of the remaining kidney for 70 minutes; the animals were studied 24 hours later. Chronic uremia was produced by unilateral nephrectomy and 70% to 80% devascularization of the remaining kidney; these animals were studied 2 weeks later. Brain uptake was studied with the technique of Oldendorf, and blood and brain amino acids (AAs) were measured. The blood urea nitrogen (BUN) level in rats with acute uremia increased to 108 mg/dl, in rats with chronic uremic 54 mg/dl, and in sham-operated rats 22 mg/dl. In both uremic groups there was a decrease in plasma branched-chain AAs. In the brain these AA levels were normal, while levels of phenylalanine, tyrosine, and histidine were increased in uremic rats.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7089866

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  9 in total

1.  Psychomotor functions at various weeks of chronic renal failure in rats.

Authors:  Merin Iype Chandanathil; Subramanya Upadhya; Sharmila Upadhya; Gopalakrishna Bhat
Journal:  Cogn Neurodyn       Date:  2014-10-28       Impact factor: 5.082

2.  A preliminary report of brain edema in patients with uremia at first hemodialysis: evaluation by diffusion-weighted MR imaging.

Authors:  C L Chen; P H Lai; K J Chou; P T Lee; H M Chung; H C Fang
Journal:  AJNR Am J Neuroradiol       Date:  2007-01       Impact factor: 3.825

3.  Acute kidney injury leads to inflammation and functional changes in the brain.

Authors:  Manchang Liu; Yideng Liang; Srinivasulu Chigurupati; Justin D Lathia; Mikhail Pletnikov; Zhaoli Sun; Michael Crow; Christopher A Ross; Mark P Mattson; Hamid Rabb
Journal:  J Am Soc Nephrol       Date:  2008-04-02       Impact factor: 10.121

Review 4.  Septic encephalopathy. Etiology and management.

Authors:  P O Hasselgren; J E Fischer
Journal:  Intensive Care Med       Date:  1986       Impact factor: 17.440

Review 5.  Brain-kidney crosstalk.

Authors:  Arkom Nongnuch; Kwanpeemai Panorchan; Andrew Davenport
Journal:  Crit Care       Date:  2014-06-05       Impact factor: 9.097

Review 6.  The role of neuroimmune and inflammation in pediatric uremia-induced neuropathy.

Authors:  Linfeng Zhu; Guoqin Tong; Fan Yang; Yijun Zhao; Guangjie Chen
Journal:  Front Immunol       Date:  2022-09-15       Impact factor: 8.786

7.  Neuronal activation in the central nervous system of rats in the initial stage of chronic kidney disease-modulatory effects of losartan and moxonidine.

Authors:  Miklós Palkovits; Katarína Šebeková; Kristina Simon Klenovics; Anton Kebis; Gholamreza Fazeli; Udo Bahner; August Heidland
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

Review 8.  The Cerebrovascular-Chronic Kidney Disease Connection: Perspectives and Mechanisms.

Authors:  Wei Ling Lau; Branko N Huisa; Mark Fisher
Journal:  Transl Stroke Res       Date:  2016-09-14       Impact factor: 6.829

9.  A link between central kynurenine metabolism and bone strength in rats with chronic kidney disease.

Authors:  Bartlomiej Kalaska; Krystyna Pawlak; Ewa Oksztulska-Kolanek; Tomasz Domaniewski; Beata Znorko; Malgorzata Karbowska; Aleksandra Citkowska; Joanna Rogalska; Alicja Roszczenko; Malgorzata M Brzoska; Dariusz Pawlak
Journal:  PeerJ       Date:  2017-04-20       Impact factor: 2.984

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.